We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$2.23B
AUM Growth
+$1.22B
Cap. Flow
+$1.34B
Cap. Flow %
60.06%
Top 10 Hldgs %
26.38%
Holding
1,418
New
876
Increased
102
Reduced
142
Closed
269

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$22.4M
2
QS icon
QuantumScape Corp
QS
+$15.9M
3
MP icon
MP Materials
MP
+$13.9M
4
RP
RealPage, Inc.
RP
+$13.5M
5
GPRE icon
Green Plains
GPRE
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.71%
2 Industrials 5%
3 Consumer Discretionary 4.69%
4 Technology 4.51%
5 Financials 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRQ.U
376
DELISTED
Spartan Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-ha
SPRQ.U
$1.1M 0.05%
99,000
-1,000
-1% -$12.6K
ALLY icon
377
Ally Financial
ALLY
$13.1B
$1.09M 0.05%
24,009
-87,895
-79% -$3.68M
SNPS icon
378
PUT
Synopsys
SNPS
$71.5B
$1.09M 0.05%
+4,400
New +$1.12M
EAF icon
379
GrafTech
EAF
$194M
$1.08M 0.05%
+9,000
New +$1.04M
SPFR.U
380
DELISTED
JAWS Spitfire Acquisition Corp Units, each consisting of one Class A ordinary share, and one-fourth
SPFR.U
$1.08M 0.05%
100,000
OWL icon
381
Blue Owl Capital
OWL
$6.39B
$1.08M 0.05%
109,319
+15,235
+16% +$158K
CRMD icon
382
CorMedix
CRMD
$617M
$1.08M 0.05%
+111,065
New +$1.17M
IDXX icon
383
PUT
Idexx Laboratories
IDXX
$42.9B
$1.08M 0.05%
+2,200
New +$1.1M
NSC icon
384
CALL
Norfolk Southern
NSC
$78.8B
$1.07M 0.05%
+4,000
New +$1.01M
PDCO
385
DELISTED
Patterson Companies, Inc.
PDCO
$1.07M 0.05%
+33,118
New +$1.06M
RUBY
386
CALL
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.06M 0.05%
+40,000
New +$584K
C icon
387
Citigroup
C
$222B
$1.05M 0.05%
14,496
-13,602
-48% -$908K
MCD icon
388
PUT
McDonald's
MCD
$188B
$1.05M 0.05%
+4,700
New +$1.01M
AGCB
389
DELISTED
Altimeter Growth Corp 2
AGCB
$1.05M 0.05%
+100,000
New +$1.19M
VYGG.U
390
DELISTED
Vy Global Growth Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant to acquire one Class A Ordinary Share
VYGG.U
$1.05M 0.05%
100,000
IMTX icon
391
Immatics
IMTX
$1.24B
$1.04M 0.05%
+93,145
New +$1.06M
RCEL icon
392
Avita Medical
RCEL
$142M
$1.04M 0.05%
+53,283
New +$1.24M
NTRS icon
393
PUT
Northern Trust
NTRS
$22.2B
$1.04M 0.05%
+9,900
New +$971K
SWK icon
394
PUT
Stanley Black & Decker
SWK
$14.2B
$1.04M 0.05%
+5,200
New +$943K
ETN icon
395
CALL
Eaton
ETN
$157B
$1.04M 0.05%
+7,500
New +$967K
PAYX icon
396
PUT
Paychex
PAYX
$40.4B
$1.03M 0.05%
+10,500
New +$967K
STSA
397
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$1.03M 0.05%
+173,029
New +$1.05M
SAII
398
DELISTED
Software Acquisition Group Inc. II Class A Common Stock
SAII
$1.02M 0.05%
102,841
+27,841
+37% +$296K
TEKKU
399
DELISTED
Tekkorp Digital Acquisition Corp. Unit
TEKKU
$1.02M 0.05%
100,000
+50,000
+100% +$552K
OZON
400
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$1.02M 0.05%
+18,158
New +$1M

Similar funds

Maven Securities's Q1 2021 Portfolio in Review

As of Q1 2021, Maven Securities held 1,418 positions worth $2.23B, up 121% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Maven Securities deployed $1.34B of net new capital in Q1 2021, opening 876 new positions and adding to 102 existing holdings. Its largest new stake was QuantumScape Corp: 303,111 shares worth $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AdaptHealth, an estimated $18.2M trimmed.

  • Maven Securities's largest Q1 2021 buy was QuantumScape Corp: 303,111 shares worth $13.5M.
  • Maven Securities added most to Invesco QQQ Trust in Q1 2021, an estimated $22.4M increase.
  • Maven Securities's biggest Q1 2021 reduction was AdaptHealth, cutting an estimated $18.2M.
  • Maven Securities fully exited Adaptive Biotechnologies in Q1 2021, selling an estimated $25.6M.
  • Maven Securities's ten largest holdings make up 26% of its $2.23B portfolio in Q1 2021.
  • Maven Securities opened 876 new positions and closed 269 in Q1 2021.
  • Maven Securities's portfolio value rose 121% quarter-over-quarter to $2.23B.

Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.